Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frederik L Giesel

Showing results (1-10 of 218) with videos related to

Pageof 22
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 11, 2017
Reply: PSMA Ligands for Imaging Prostate Cancer: Alternative Labeling by Complex Formation with Al<sup>18</sup>F<sup>2</sup>Frederik L Giesel, Klaus Kopka
AJR. American Journal of Roentgenology|December 17, 2025
A Milestone in Clinical FAPI PET: High Accuracy of [<sup>68</sup>Ga]Ga-FAPI-46 PET/CT in a Prospective Phase 2 TrialYuriko Mori, Frederik L Giesel
PET Clinics|April 8, 2023
Fibroblast Activation Protein Inhibitor PET/CT in Gastric CancerTadashi Watabe, Frederik L Giesel
Seminars in Nuclear Medicine|June 23, 2019
Radionuclide Therapy of Metastatic Prostate CancerClemens Kratochwil, Uwe Haberkorn, Frederik L Giesel
European Radiology|June 23, 2010
High-relaxivity contrast-enhanced magnetic resonance neuroimaging: a reviewFrederik L Giesel, Amit Mehndiratta, Marco Essig
European Radiology|May 12, 2023
<sup>68</sup>Ga- or <sup>18</sup>F-FAPI PET/CT-what it can and cannotYuriko Mori, Uwe Haberkorn, Frederik L Giesel
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 28, 2025
Pretargeting: Bridging the two worlds of radiopharmaceutical probesYuriko Mori, Jens Cardinale, Frederik L Giesel
European Urology Focus|September 25, 2020
Prostate-specific Membrane Antigen Imaging and Theranostics Impact Patient OutcomesBoris A Hadaschik, Frederik L Giesel, Kim Chi
PET Clinics|April 30, 2023
Fibroblast Activation Protein as a Diagnostic and Therapeutic Target: Where Do We Go from Here?Rodney J Hicks, Frederik L Giesel, Ken Herrmann
PET Clinics|April 8, 2023
Fibroblast Activation Protein Inhibitor Theranostics: Early Clinical TranslationYuriko Mori, Clemens Kratochwil, Uwe Haberkorn, et al.
Pageof 22

Showing results (1-10 of 218) with videos related to

Sort By:
Pageof 22
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 11, 2017
Reply: PSMA Ligands for Imaging Prostate Cancer: Alternative Labeling by Complex Formation with Al<sup>18</sup>F<sup>2</sup>Frederik L Giesel, Klaus Kopka
AJR. American Journal of Roentgenology|December 17, 2025
A Milestone in Clinical FAPI PET: High Accuracy of [<sup>68</sup>Ga]Ga-FAPI-46 PET/CT in a Prospective Phase 2 TrialYuriko Mori, Frederik L Giesel
PET Clinics|April 8, 2023
Fibroblast Activation Protein Inhibitor PET/CT in Gastric CancerTadashi Watabe, Frederik L Giesel
Seminars in Nuclear Medicine|June 23, 2019
Radionuclide Therapy of Metastatic Prostate CancerClemens Kratochwil, Uwe Haberkorn, Frederik L Giesel
European Radiology|June 23, 2010
High-relaxivity contrast-enhanced magnetic resonance neuroimaging: a reviewFrederik L Giesel, Amit Mehndiratta, Marco Essig
European Radiology|May 12, 2023
<sup>68</sup>Ga- or <sup>18</sup>F-FAPI PET/CT-what it can and cannotYuriko Mori, Uwe Haberkorn, Frederik L Giesel
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 28, 2025
Pretargeting: Bridging the two worlds of radiopharmaceutical probesYuriko Mori, Jens Cardinale, Frederik L Giesel
European Urology Focus|September 25, 2020
Prostate-specific Membrane Antigen Imaging and Theranostics Impact Patient OutcomesBoris A Hadaschik, Frederik L Giesel, Kim Chi
PET Clinics|April 30, 2023
Fibroblast Activation Protein as a Diagnostic and Therapeutic Target: Where Do We Go from Here?Rodney J Hicks, Frederik L Giesel, Ken Herrmann
PET Clinics|April 8, 2023
Fibroblast Activation Protein Inhibitor Theranostics: Early Clinical TranslationYuriko Mori, Clemens Kratochwil, Uwe Haberkorn, et al.
Pageof 22